US20160305956A1 - Elevated ccl19 after completion of therapy for acute lyme disease identifies patients at risk for development of post-treatment lyme disease syndrome who will benefit from further antibiotic therapy - Google Patents

Elevated ccl19 after completion of therapy for acute lyme disease identifies patients at risk for development of post-treatment lyme disease syndrome who will benefit from further antibiotic therapy Download PDF

Info

Publication number
US20160305956A1
US20160305956A1 US15/131,063 US201615131063A US2016305956A1 US 20160305956 A1 US20160305956 A1 US 20160305956A1 US 201615131063 A US201615131063 A US 201615131063A US 2016305956 A1 US2016305956 A1 US 2016305956A1
Authority
US
United States
Prior art keywords
lyme disease
ccl19
treatment
levels
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/131,063
Inventor
John N. Aucott
Mark J. Soloski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201562148332P priority Critical
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Priority to US15/131,063 priority patent/US20160305956A1/en
Publication of US20160305956A1 publication Critical patent/US20160305956A1/en
Assigned to THE JOHNS HOPKINS UNIVERSITY reassignment THE JOHNS HOPKINS UNIVERSITY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AUCOTT, JOHN N., SOLOSKI, MARK J.
Abandoned legal-status Critical Current

Links